Low- and middle-income countries bear a disproportionate burden of gynecologic malignancies—cancers of the cervix, endometrium, ovary, vagina, and vulva. A review published by Wiley online in CANCER reveals that survival disparities for these cancers are driven by late-stage diagnosis, limited screening coverage, inadequate radiotherapy infrastructure, workforce shortages, and restricted access to essential and novel therapies.

Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly known as drugs for diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research has found.

A new Cochrane evidence and gap map (EGM) has mapped the global research landscape on dengue prevention, finding plenty of research but not enough of it synthesized in ways policymakers can use.

**Note this is an early release from the Annual Meeting of the European Association for the Study of Diabetes [EASD]. Please credit the meeting when using this research**

Type 2 diabetes has traditionally been a disease that has developed mostly in middle-aged and older adults. But new research from the USA to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows a sharp increase in the rate of new cases of type 2 diabetes since the turn of the century, which has continued to accelerate in recent years. The study is by Dr Tessa Crume, Colorado School of Public Health, Aurora, CO, USA, and colleagues.